论文部分内容阅读
目的观察常规抗风湿药联合血必净治疗类风湿关节炎(RA)的临床效果。方法选取医院收治的类风湿关节炎患者80例作为研究对象,随机分为观察组和对照组,每组40例。对照组采用常规抗风湿药进行治疗,观察组则在对照组基础上接受血必净治疗,观察2组患者的炎性指标[C反应蛋白(CRP)、红细胞沉降率(ESR)、IL-6]、临床指标(晨僵时间、关节压痛个数、关节肿胀个数)及治疗效果。结果观察组总有效率为95.0%,高于对照组的85.0%(P<0.05)。治疗后,观察组CRP、ESR及IL-6指标均优于对照组(P<0.05)。观察组晨僵时间、关节压痛个数及关节肿胀个数均优于对照组(P<0.05)。结论常规抗风湿药联合血必净治疗类风湿关节炎临床效果显著,具有广泛推广价值。
Objective To observe the clinical effect of conventional anti-rheumatic drugs combined with Xuebijing in the treatment of rheumatoid arthritis (RA). Methods Eighty patients with rheumatoid arthritis admitted to hospital were selected as study subjects and randomly divided into observation group and control group with 40 cases in each group. The control group was treated with conventional anti-rheumatic drugs. The observation group received Xuebijing treatment on the basis of the control group. Inflammatory index (C-reactive protein, erythrocyte sedimentation rate, IL-6 ], Clinical indicators (morning stiffness time, the number of joint tenderness, the number of joint swelling) and treatment. Results The total effective rate in the observation group was 95.0%, which was higher than that in the control group (85.0%, P <0.05). After treatment, CRP, ESR and IL-6 in observation group were better than those in control group (P <0.05). Morning stiffness time, the number of joint tenderness and the number of joint swelling in the observation group were better than those in the control group (P <0.05). Conclusion Conventional anti-rheumatic drugs combined with Xuebijing treatment of rheumatoid arthritis clinical effect is significant, with a wide range of promotional value.